Ledger.Open graph →

SEC Form D · filed December 27, 2018

Rhoshan Pharmaceuticals, Inc

Offering

$19.3M

Sold

$19.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

GLEN MILLS, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Nagesh J. Palepu · Southampton, PAExec · Director Kevin J. O'Neill · Glen Mills, PAExec · Director Hitha J. Palepu · New York, NYExec · Director Tom D. Tipton · Dallas, TXExec · Director Robert Gritz · Austin, TXExec · Director Andrew Reed · San Francisco, CAExec · Director Zach Gut · Greenwich, CTExec · Director Erica F. Blob · Greenwich, CTExec · Director William Scott · Estero, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗